Global Neonatal Intensive Care Respiratory Devices Market OverviewThe global neonatal intensive care respiratory devices market is projected to grow at a compound annual growth rate of approximately 6 ...
Advent Therapeutics is developing vitamin A therapies aimed at preventing chronic lung disease in premature babies.
Bronchiolitis remains the leading cause of hospital admission in infancy and of paediatric intensive care unit use.1 Management of bronchiolitis has been largely limited to supportive care, reflecting ...
High-frequency oscillatory ventilation (HFOV) has established itself as a valuable technique in the management of neonatal respiratory distress. By utilising very small tidal volumes at rapid rates, ...
Industry Leader Will Also Showcase Its Trusted NKV Series—Recognized by Top Hospitals Across the U.S. for its Intelligent Automation and Clinical Precision—at Booth #905; Where Clinical Experts will ...
High-frequency oscillatory ventilation (HFOV) reduced bronchopulmonary dysplasia in preterm infants with neonatal respiratory ...
Use of antenatal corticosteroid in twin pregnancies at risk of late preterm delivery reduced the risk of severe neonatal respiratory morbidity. Risk was only reduced in neonates delivered between 12 ...
Manning Family Children’s has been honored with the Vermont Oxford Network (VON) Award for Excellence in Quality Improvement, ...
As parents, we always want what’s best for our children, especially when it comes to medical care. That’s where a Level III Neonatal Intensive Care Unit (NICU) comes in. If your delivery doesn’t go ...
As parents, we always want what’s best for our children, especially when it comes to medical care. That’s where a Level III Neonatal Intensive Care Unit (NICU) comes in. If your delivery doesn’t go ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results